Amlodipine as Besylate Atorvastatin as calcium

AIT Pharmaceuticals Division: Enhancing Cardiovascular Health

Introduction:

Welcome to AIT Pharmaceuticals Division, your trusted partner in promoting cardiovascular well-being. Our commitment to excellence and patient care is evident in our Amlodipine as Besylate Atorvastatin as Calcium Range, a groundbreaking medication designed to manage hypertension and hyperlipidemia simultaneously.

Share

Description

Pharmacokinetics and Pharmacodynamics:

Amlodipine, as besylate, and atorvastatin, as calcium, are combined in this innovative formulation to address both hypertension and hypercholesterolemia. Amlodipine, a calcium channel blocker, relaxes blood vessels, reducing blood pressure and improving blood flow. Atorvastatin, a statin medication, inhibits cholesterol synthesis, lowering LDL cholesterol levels and reducing the risk of cardiovascular events.

Drug Classification:

This product is classified as a combination medication, containing an antihypertensive agent (amlodipine) and a lipid-lowering agent (atorvastatin). Amlodipine is categorized as a dihydropyridine calcium channel blocker, while atorvastatin belongs to the statin class of drugs.

Formulations:

Our Amlodipine as Besylate Atorvastatin as Calcium Range is available in tablet form, with strengths of 5 mg and 10 mg for amlodipine and atorvastatin, respectively. Each pack contains 20 tablets, providing a convenient and standardized dosage regimen for patients requiring dual therapy for hypertension and hyperlipidemia.

Indications:

This combination medication is indicated for the management of hypertension and dyslipidemia in patients who require treatment for both conditions. It is particularly beneficial for individuals with comorbid cardiovascular risk factors, such as hypertension and elevated LDL cholesterol levels.

Usage:

The tablets should be taken orally, with or without food, as directed by a healthcare professional. It is essential to adhere to the prescribed treatment regimen and follow any dietary or lifestyle recommendations provided by the healthcare provider. Regular monitoring of blood pressure and lipid levels is recommended to assess treatment efficacy and adjust therapy as needed.

Dosage:

The recommended starting dose of Amlodipine as Besylate Atorvastatin as Calcium is typically 5 mg/10 mg once daily. Dosage adjustments may be made based on individual patient response and tolerability. Higher doses may be required for patients with severe hypertension or hyperlipidemia, but dosage escalation should be done cautiously and under medical supervision.

Side Effects:

Common side effects of this combination medication may include headache, dizziness, flushing, peripheral edema, myalgia, and gastrointestinal disturbances. Rare but serious side effects may include hepatotoxicity, rhabdomyolysis, and allergic reactions. Patients should be monitored closely for adverse reactions, and healthcare providers should be notified of any concerning symptoms.

Conclusion:

Trust AIT Pharmaceuticals Division for comprehensive cardiovascular care with our Amlodipine as Besylate Atorvastatin as Calcium Range. Empower yourself or your loved ones to manage hypertension and hyperlipidemia effectively with our innovative medication. Choose AIT Pharmaceuticals Division for personalized support and superior treatment options tailored to your cardiovascular needs.

 

Reviews

There are no reviews yet.

Be the first to review “Amlodipine as Besylate Atorvastatin as calcium”

Your email address will not be published. Required fields are marked *

Shopping Basket